Nrx pharmaceuticals announces $30 million private placement

Radnor, pa., aug. 19, 2021 /prnewswire/ -- nrx pharmaceuticals (nrx) (nasdaq: nrxp) (or the "company"), a delaware corporation, today announced that it has entered into definitive agreements with investors to purchase 2,727,273 shares of common stock in a private placement.
NRXP Ratings Summary
NRXP Quant Ranking